Clinical Trial Update: Assessing Circulating Tumor Cell as a Biomarker for Prostate Cancer Detection in Patients With Gray Zone PSA Level

View source ↗

Summary

The trial update covers an investigation into whether circulating tumor cells can serve as a biomarker for detecting prostate cancer in men with gray-zone PSA l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: CellMaxLife | Conditions: Prostate Cancer | Status: UNKNOWN